Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07353333
Eligibility Criteria:
Inclusion Criteria:
1. the subject or his/her legal representative can sign and date the informed consent form
2. commitment to follow the research procedures and cooperate in the implementation of the full-process research
3. patients with high clinical suspicion or histopathology diagnosis of HCC and generally in good condition
4. patients with a history of hepatocellular carcinoma who recur after treatment
5. women in their reproductive years were using contraception for at least one month before screening and were committed to using contraception throughout the study period and for the prescribed period after the end of the study
Exclusion Criteria:
1. inability to complete SPECTCT examination (including inability to lie down, claustrophobia, radiophobia, etc.)
2. acute systemic diseases and electrolyte disorders
3. patients with known hypersensitivity to GPC3 imaging agents or synthetic excipients
4. patients considered by the investigator to have poor adherence
5. pregnant or lactating patients
6. Have other factors not suitable to participate in this test
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07353333
Study Brief:
Protocol Section:
NCT07353333